Hsbc Holdings PLC Catalent, Inc. Transaction History

Hsbc Holdings PLC

$168 Billion
Q3 2024

A detailed history of Hsbc Holdings PLC transactions in Catalent, Inc. stock. As of the latest transaction made, Hsbc Holdings PLC holds 700,101 shares of CTLT stock, worth $41.2 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

700,101

Previous 981,722 28.69%

Holding current value

$41.2 Million

Previous $55.2 Million 23.18%

% of portfolio

0.03%

Previous 0.03%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$56.16 - $60.96 $15.8 Million - $17.2 Million	-281,621 Reduced 28.69%	700,101 $42.4 Million
Q2 2024 Aug 12, 2024	BUY	$53.58 - $57.02 $21.5 Million - $22.9 Million	401,469 Added 69.19%	981,722 $55.2 Million
Q1 2024 May 15, 2024	BUY	$42.56 - $59.82 $9.11 Million - $12.8 Million	214,029 Added 58.44%	580,253 $32.8 Million
Q4 2023 Feb 12, 2024	BUY	$32.18 - $46.57 $5.56 Million - $8.05 Million	172,902 Added 89.44%	366,224 $16.5 Million
Q3 2023 Nov 13, 2023	BUY	$44.2 - $50.2 $2.57 Million - $2.92 Million	58,240 Added 43.11%	193,322 $8.8 Million
Q2 2023 Aug 11, 2023	SELL	$31.86 - $67.26 $2.47 Million - $5.22 Million	-77,646 Reduced 36.5%	135,082 $5.86 Million
Q1 2023 May 15, 2023	SELL	$45.44 - $74.26 $7.31 Million - $11.9 Million	-160,764 Reduced 43.04%	212,728 $14 Million
Q4 2022 Feb 14, 2023	BUY	$41.39 - $81.0 $9 Million - $17.6 Million	217,430 Added 139.32%	373,492 $16.8 Million
Q3 2022 Nov 14, 2022	SELL	$72.36 - $113.1 $508,618 - $794,979	-7,029 Reduced 4.31%	156,062 $11.5 Million
Q2 2022 Aug 11, 2022	BUY	$87.2 - $114.05 $768,842 - $1.01 Million	8,817 Added 5.72%	163,091 $17.5 Million
Q1 2022 May 16, 2022	SELL	$94.19 - $124.49 $402,850 - $532,443	-4,277 Reduced 2.7%	154,274 $17.1 Million
Q4 2021 Feb 11, 2022	BUY	$119.57 - $139.07 $1.32 Million - $1.53 Million	11,010 Added 7.46%	158,551 $20.3 Million
Q3 2021 Nov 12, 2021	BUY	$109.17 - $142.35 $1.83 Million - $2.38 Million	16,754 Added 12.81%	147,541 $19.7 Million
Q2 2021 Aug 13, 2021	SELL	$100.34 - $115.69 $2.09 Million - $2.41 Million	-20,871 Reduced 13.76%	130,787 $14.1 Million
Q1 2021 May 14, 2021	SELL	$101.51 - $125.27 $1.61 Million - $1.98 Million	-15,844 Reduced 9.46%	151,658 $16 Million
Q4 2020 Feb 12, 2021	BUY	$85.88 - $105.36 $3.39 Million - $4.16 Million	39,477 Added 30.84%	167,502 $17.4 Million
Q3 2020 Nov 12, 2020	BUY	$72.74 - $92.5 $8.32 Million - $10.6 Million	114,446 Added 842.82%	128,025 $11 Million
Q2 2020 Aug 14, 2020	SELL	$48.02 - $79.04 $417,053 - $686,462	-8,685 Reduced 39.01%	13,579 $996,000
Q1 2020 May 15, 2020	BUY	$36.95 - $62.95 $259,795 - $442,601	7,031 Added 46.16%	22,264 $1.14 Million
Q4 2019 Feb 14, 2020	SELL	$47.06 - $56.64 $583,920 - $702,789	-12,408 Reduced 44.89%	15,233 $857,000
Q3 2019 Nov 14, 2019	BUY	$47.45 - $58.05 $667,147 - $816,183	14,060 Added 103.53%	27,641 $1.32 Million
Q2 2019 Aug 13, 2019	SELL	$39.26 - $54.21 $578,260 - $798,459	-14,729 Reduced 52.03%	13,581 $736,000
Q1 2019 May 15, 2019	BUY	$29.84 - $43.92 $269,216 - $396,246	9,022 Added 46.78%	28,310 $1.15 Million
Q4 2018 Feb 13, 2019	SELL	$29.95 - $46.34 $147,054 - $227,529	-4,910 Reduced 20.29%	19,288 $602,000
Q3 2018 Nov 13, 2018	BUY	$40.12 - $45.55 $101,222 - $114,922	2,523 Added 11.64%	24,198 $1.1 Million
Q2 2018 Aug 10, 2018	SELL	$38.72 - $42.52 $1.76 Million - $1.93 Million	-45,505 Reduced 67.74%	21,675 $908,000
Q1 2018 May 11, 2018	BUY	$39.4 - $47.39 $1.94 Million - $2.33 Million	49,118 Added 271.94%	67,180 $2.76 Million
Q4 2017 Feb 14, 2018	BUY	$37.27 - $43.02 $37,940 - $43,794	1,018 Added 5.97%	18,062 $743,000
Q3 2017 Nov 14, 2017	BUY	$33.75 - $41.67 $38,272 - $47,253	1,134 Added 7.13%	17,044 $681,000
Q2 2017 Aug 14, 2017	BUY	N/A	15,910	15,910 $558,000

Others Institutions Holding CTLT

# of Institutions

510

Shares Held

150M

Call Options Held

510K

Put Options Held

View Full List

About Catalent, Inc.

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $10.6B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

More about CTLT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.

Account

Hsbc Holdings PLC Catalent, Inc. Transaction History